I agree valery. Very good sign is moderate improvement in volume. If they really go to investor conference and adopt investor friendly practices and improve corp governance, the daily volume will likely quadruple to 100-150k shares and price will likely triple.
i received an unsubstantiated rumor from a shareholder that pricing has been increased on 20 drugs. I still do not know the source of this data (apparently it is not IMS). Maybe this pricing increase can be seen in retail pharmacy ? I don't know. I also don't know how big these 20 drugs are wrt overall taro sales.